Assessing multiple sclerosis disease activity using the MSDA blood biomarker test can help guide decisions about care, per a study.

Some types of exercises are better than others at easing specific issues associated with balance for people with MS, a small ...

One year of Tysabri infusion improved working ability for relapsing-remitting multiple sclerosis (RRMS) patients in France, ...

Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

Aranzazu Calzado, known to friends as Zazu, has lived in Houston since 1996 after moving from Spain. Diagnosed with primary ...

MS patients in rural areas are 17% less likely to receive DMTs than those in urban areas, a study of Alberta, Canada, ...

Biostate AI and the Accelerated Cure Project will to develop AI models to predict multiple sclerosis progression and ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

This week's Guest Voice features Aranzazu Calzado, who says she was terrified to learn she had MS. Today, she's proud of her resilience.

Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a ...

Barry Singer, MD, is the Director of the MS Center for Innovations in Care at Missouri Baptist Medical Center in St. Louis, Missouri. He explains why it’s important to have clear expectations ...